Skin Diseases

The grounding supports multiple etiologic categories rather than a single cause. These include chemically induced disease, infectious organisms, allergens, systemic toxicity, immune-mediated reactions such as graft-versus-host disease, and UV- or chronologic damage associated with mitochondrial oxidative injury.

The literature emphasizes disrupted skin homeostasis in a high-turnover tissue that depends on rapid progenitor-cell proliferation and mitochondrial energy production. Mitochondrial respiration generates reactive oxygen species that can damage cellular structures, and immune signaling pathways such as JAK/STAT, IL-17A/IL-23, and IL-4/IL-13 are highlighted in inflammatory skin disease. Plasma-related effects described in the grounding also include antimicrobial, anti-inflammatory, tissue-stimulating, and proapoptotic actions.

Supported risk factors include exposure to chemicals, allergens, infectious organisms, systemic toxicity, UV exposure, and aging-related oxidative stress. The grounding also indicates that allogeneic hematopoietic stem cell transplantation is a risk context for cutaneous graft-versus-host disease.

The supplied abstracts support treatment at the modality and drug-class level rather than a single standard regimen. These include topical and systemic JAK inhibitors, skin-directed therapies for cutaneous graft-versus-host disease, and advanced transdermal delivery approaches such as nanocarriers and microneedles to improve local drug delivery. Cold atmospheric pressure plasma is also described as an emerging dermatologic treatment modality.